TNF-α suppresses IFN-γ-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1435-1440

  Han, Yulong ^a   Lucy Zhou, Z H ^a   Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CANCER GROWTH FACTOR; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSCRIPTION; TRANSACTIVATION;

FIBROSARCOMA; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; MUTATION; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TETRACYCLINE; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344731328     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Mach, B. 1995. MHC class II regulation: lessons from a disease. N. Engl. J. Med. 332:120.
2. Grusby, M. J., and L. H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:417.
3. Rohn, W. M., Y.-J. Lee, and E. N. Benveniste. 1996. Regulation of class II MHC expression. Crit. Rev. Immunol. 16:311.
4. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 13:50.
5. Ting, J. P., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8.
6. Abdulkadir, S. A., and S. J. Ono. 1995. How are class II MHC gene turned on and off? FASEB J. 9:1429.
7. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
8. Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020.
9. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
10. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific compex formation between the type II bare lymphocyte syndrome-associated trans-activators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 89:11518.
11. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the trans-activator gene CIITA. Science 265:106.
12. Chin, K. C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and B3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
13. Lee, Y.-J., Y. Han, H. T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II trans-activator messenger RNA expression. J. Immunol. 158:2065.
14. Otten, L. A., V. Steimle, S. Bontron, and B. Mach. 1998. Quantitative control of MHC class II expression by the trans-activator CIITA. Eur. J. Immunol. 28:473.
15. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II trans-activator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
16. Chang, C.-H., S. Guerder, S.-C. Hong, W. V. Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II trans-activator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
17. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
18. Lu, H. T., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon-β acts downstream of IFN-γ-induced CIITA mRNA accumulation to block MHC class II gene expression and requires the 48-kDa DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
19. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135:1857.
20. Watanabe, Y., and C. O. Jacob. 1991. Regulation of MHC class II antigen expression: opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. J. Immunol. 146:899.
21. Wynn, T. A., Y. R. Freund, and D. M. Paulnock. 1992. TNF-α differentially regulates Ia antigen expression and macrophage tumoricidal activity in two murine macrophage cell lines. Cell. Immunol. 140:184.
22. Chang, R. J., and S. H. Lee. 1986. Effects of interferon-γ and tumor necrosis factor-α on the expression of Ia antigen on a murine macrophage cell line. J. Immunol. 137:1853.
23. Pfizenmaier, K., P. Scheurich, C. Schluter, and M. Kronke. 1987. Tumor necrosis factor enhances HLA-A,B,C, and HLA-DR gene expression in human tumor cells. J. Immunol. 138:975.
24. Arenzana-Seisdedos, F., S. C. Mogensen, F. Vuillier, W. Fiers, and J.-L. Virelizier. 1988. Autocrine secretion of tumor necrosis factor under the influence of interferon-γ amplifies HLA-DR gene induction in human monocytes. Proc. Natl. Acad. Sci. USA 85:6087.
25. Hoffman, M., and J. B. Weinberg. 1987. Tumor necrosis factor-α induce increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages. J. Leukocyte Biol. 42:704.
26. Leeuwenberg, J. F., J. Van Damme, T. Meager, T. M. Jeunhomme, and W. A. Buurman. 1988. Effects of tumor necrosis factor on the interferon-γ-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur. J. Immunol. 18:1469.
27. Freund, Y. R., R. L. Dedrick, and P. P. Jones. 1990. cis-acting sequences required for class II gene regulation by interferon γ and tumor necrosis factor α in a murine macrophage cell line. J. Exp. Med. 171:1283.
28. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and tumor necrosis factor-α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J. Immunol. 150:1205.
29. Vidovic, M., S. M. Sparacio, M. Elovitz, and E. N. Benveniste. 1990. Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α. J. Neuroimmunol. 30:189.
30. Pellegrini, S., J. John, M. Shearer, I. M. Kerr, and G. R. Stark. 1989. Use of a selectable marker regulated by α interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:4605.
31. John, M. J., R. McKendry, S. Pellegrini, D. Flavell, I. M. Kerr, and G. R. Stark. 1991. Isolation and characterization of a new mutant human cell line unresponsive to α and β interferons. Mol. Cell. Biol. 11:4189.
32. Hocevar, B. A., and P. H. Howe. 1996. Isolation and characterization of mutant cell lines defective in transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA 93:7655.
33. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92:8493.
34. Mach, B., V. Steimle, and W. Reith. 1994. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol. Rev. 138:207.
35. Ross, J. 1995. mRNA Stability in mammalian cells. Microbiol. Rev. 59:423.
36. Ross, J. 1996. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 12:171.
37. Wellington, C. L., M. E. Greenberg, and J. G. Belasco. 1993. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol. Cell. Biol. 13:5034.
38. Chen, C.-Y., Y. You, and A.-B. Shyu. 1992. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of c-fos protein-coding region determinant of mRNA instability. Mol. Cell. Biol. 12:5748.
39. Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitor. Genes Dev. 5:232.
40. Prokipcak, R. D., D. J. Herrick, and J. Ross. 1994. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J. Biol. Chem. 269:9261.
41. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminal of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
42. Kobe, B., and J. Deisenhofer. 1995. Proteins with leucine-rich repeats. Curr. Opin. Struct. Biol. 5:409.
43. Chin, K. C., G. Li, and J. P.-Y. Ting. 1997. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II trans-activator deletion mutants. J. Immunol. 159:2789.
44. Bontron, C., V. Steimle, C. Ucla, and B. Mach. 1997. Two novel mutations in the MHC class II trans-activator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99:541.
45. Bontron, S., C. Ucla, B. Mach, and V. Steimle. 1997. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell. Biol. 17:4249.
46. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the trans-activator CIITA. EMBO J. 16:2851.
47. Devajyothi, C., I. Kalvakolanu, G. T. Babcock, H. A. Vasavada, P. H. Howe, and R. M. Ransohoff. 1993. Inhibition of interferon-γ-induced gene transcription by interferon β and type β1 transforming growth factor in human astrocytoma cells: definition of cis element. J. Biol. Chem. 268:18794.
48. Sicher, S. C., G. W. Chung, M. A. Vazquez, and C. Y. Lu. 1995. Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides: the roles of TNF-α and nitric oxide, and the importance of the sequence of signaling. J. Immunol. 155:5826.
49. Frei, K., H. Lins, C. Schwerdel, and A. Fontana. 1994. Antigen presentation in the central nervous system: the inhibitory effect of IP-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:2720.